# Jade Biosciences, Inc.: filings

JBIO · Nasdaq · CIK 1798749 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/jbio.md) · [Financials](/companies/jbio/financials.md) · [Filings](/companies/jbio/filings.md) · [Insiders](/companies/jbio/insiders.md)

## Reports and events: 108 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 184, 8-K 59, 144 52, 3 30, 425 17, 10-Q 16, CORRESP 14, SCHEDULE 13G/A 11, SC 13G/A 9, SCHEDULE 13G 9, UPLOAD 9, 424B3 8, SC 13D/A 8, EFFECT 7, S-8 7, 10-K 5, DEFA14A 5, SCHEDULE 13D/A 5, ARS 4, DEF 14A 4, S-3 4, S-4/A 4, SC 13G 4, 424B5 3, S-1 3, S-1/A 3, SC 13D 3, D 2, POS EX 2, SEC STAFF LETTER 2, 424B4 1, 8-A12B 1, 8-A12B/A 1, 8-K/A 1, CERT 1, DRS 1, PRE 14A 1, RW 1, S-1MEF 1, S-4 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-30 | 07:13 ET | [8-K](/filings/0001193125-26-408287.md) | 8.01 Other events | 0001193125-26-408287 |
| 2026-08-10 | 07:21 ET | [10-Q](/filings/0001193125-26-341242.md) | Quarterly report, period 2026-06-30 | 0001193125-26-341242 |
| 2026-08-10 | 07:13 ET | [8-K](/filings/0001193125-26-341229.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-341229 |
| 2026-07-01 | 16:41 ET | [8-K](/filings/0001193125-26-292704.md) | 1.01 Entry into a material agreement | 0001193125-26-292704 |
| 2026-06-26 | 07:15 ET | [8-K](/filings/0001193125-26-283906.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-283906 |
| 2026-06-11 | 16:28 ET | [8-K](/filings/0001193125-26-267640.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-267640 |
| 2026-06-09 | 17:30 ET | [SCHEDULE 13D/A](/filings/0001104659-26-071942.md) | Ownership report, active investor, amended | 0001104659-26-071942 |
| 2026-06-04 | 17:09 ET | [8-K](/filings/0001193125-26-257733.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-257733 |
| 2026-06-01 | 07:55 ET | [8-K](/filings/0001193125-26-249763.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-249763 |
| 2026-05-07 | 16:27 ET | [10-Q](/filings/0001193125-26-212088.md) | Quarterly report, period 2026-03-31 | 0001193125-26-212088 |
| 2026-05-07 | 16:16 ET | [8-K](/filings/0001193125-26-211973.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-211973 |
| 2026-04-28 | 16:12 ET | [DEF 14A](/filings/0001193125-26-187059.md) | Proxy statement, period 2026-06-09 | 0001193125-26-187059 |
| 2026-04-22 | 07:18 ET | [8-K](/filings/0001193125-26-168351.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-168351 |
| 2026-04-02 | 16:10 ET | [8-K](/filings/0001193125-26-140091.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-140091 |
| 2026-03-06 | 16:15 ET | [10-K](/filings/0001193125-26-096550.md) | Annual report, period 2025-12-31 | 0001193125-26-096550 |
| 2026-03-06 | 07:11 ET | [8-K](/filings/0001193125-26-094967.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-094967 |
| 2026-03-05 | 06:04 ET | [SCHEDULE 13D/A](/filings/0001104659-26-023732.md) | Ownership report, active investor, amended | 0001104659-26-023732 |
| 2026-01-05 | 07:17 ET | [8-K](/filings/0001193125-26-001502.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-001502 |
| 2025-12-22 | 16:38 ET | [S-1](/filings/0001193125-25-328848.md) | Registration statement | 0001193125-25-328848 |
| 2025-12-15 | 07:11 ET | [8-K](/filings/0001193125-25-318436.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-318436 |
| 2025-11-14 | 16:09 ET | [S-1](/filings/0001193125-25-282921.md) | Registration statement | 0001193125-25-282921 |
| 2025-11-14 | 07:13 ET | [10-Q](/filings/0001193125-25-281525.md) | Quarterly report, period 2025-09-30 | 0001193125-25-281525 |
| 2025-11-14 | 07:00 ET | [8-K](/filings/0001193125-25-281498.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-281498 |
| 2025-10-08 | 16:15 ET | [SCHEDULE 13D/A](/filings/0001104659-25-097923.md) | Ownership report, active investor, amended | 0001104659-25-097923 |
| 2025-10-07 | 07:13 ET | [8-K](/filings/0001193125-25-232562.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-232562 |
| 2025-09-09 | 07:13 ET | [8-K](/filings/0001193125-25-198777.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-198777 |
| 2025-08-13 | 16:20 ET | [10-Q](/filings/0001193125-25-179853.md) | Quarterly report, period 2025-06-30 | 0001193125-25-179853 |
| 2025-08-13 | 16:14 ET | [8-K](/filings/0001193125-25-179828.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-179828 |
| 2025-07-01 | 07:08 ET | [8-K](/filings/0001193125-25-153427.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-153427 |
| 2025-05-14 | 16:12 ET | [8-K](/filings/0001193125-25-119856.md) | 2.01 Completion of an acquisition or disposition; 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-119856 |
| 2025-05-01 | 18:31 ET | [SCHEDULE 13D](/filings/0000950170-25-062146.md) | Ownership report, active investor | 0000950170-25-062146 |
| 2025-05-01 | 16:22 ET | [8-K](/filings/0001193125-25-110004.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.02 Results of operations; 3.03 Change to security holders’ rights; 4.01 Change of auditor; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.05 Item not in the standard list; 5.06 Item not in the standard list; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-110004 |
| 2025-04-30 | 16:51 ET | [SCHEDULE 13D/A](/filings/0001415889-25-011581.md) | Ownership report, active investor, amended | 0001415889-25-011581 |
| 2025-04-30 | 16:29 ET | [SCHEDULE 13D/A](/filings/0001415889-25-011576.md) | Ownership report, active investor, amended | 0001415889-25-011576 |
| 2025-04-29 | 16:05 ET | [8-K](/filings/0001193125-25-103761.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-103761 |
| 2025-04-25 | 16:30 ET | [10-Q](/filings/0001558370-25-005564.md) | Quarterly report, period 2025-03-31 | 0001558370-25-005564 |
| 2025-04-23 | 16:37 ET | [8-K](/filings/0001558370-25-005278.md) | 8.01 Other events | 0001558370-25-005278 |
| 2025-04-21 | 08:07 ET | [8-K](/filings/0001104659-25-036566.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-036566 |
| 2025-04-09 | 16:09 ET | [8-K](/filings/0001104659-25-033397.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-033397 |
| 2025-04-09 | 07:00 ET | [8-K](/filings/0001104659-25-033200.md) | 8.01 Other events | 0001104659-25-033200 |
| 2025-04-07 | 08:39 ET | [8-K](/filings/0001558370-25-004511.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-004511 |
| 2025-03-27 | 07:30 ET | [10-K](/filings/0001558370-25-003750.md) | Annual report, period 2024-12-31 | 0001558370-25-003750 |
| 2024-11-12 | 16:40 ET | [10-Q](/filings/0001798749-24-000059.md) | Quarterly report, period 2024-09-30 | 0001798749-24-000059 |
| 2024-10-31 | 09:27 ET | [8-K](/filings/0001104659-24-112896.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-112896 |
| 2024-10-17 | 16:59 ET | [8-K](/filings/0001798749-24-000055.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001798749-24-000055 |
| 2024-10-10 | 17:04 ET | [8-K](/filings/0001798749-24-000052.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001798749-24-000052 |
| 2024-08-12 | 16:31 ET | [10-Q](/filings/0001798749-24-000049.md) | Quarterly report, period 2024-06-30 | 0001798749-24-000049 |
| 2024-07-08 | 08:00 ET | [8-K](/filings/0001798749-24-000042.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001798749-24-000042 |
| 2024-07-01 | 16:03 ET | [8-K/A](/filings/0001798749-24-000039.md) | 2.05 Exit or disposal costs | 0001798749-24-000039 |
| 2024-06-28 | 16:59 ET | [8-K](/filings/0001798749-24-000036.md) | 2.05 Exit or disposal costs | 0001798749-24-000036 |

Page 1 of 3. [Older](/companies/jbio/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.